223 related articles for article (PubMed ID: 21075272)
21. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
22. Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone.
Dean RL; Todtenkopf MS; Deaver DR; Arastu MF; Dong N; Reitano K; O'Driscoll K; Kriksciukaite K; Gastfriend DR
Pharmacol Biochem Behav; 2008 Jun; 89(4):515-22. PubMed ID: 18342360
[TBL] [Abstract][Full Text] [Related]
23. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N
J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961
[TBL] [Abstract][Full Text] [Related]
24. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
[TBL] [Abstract][Full Text] [Related]
25. Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.
Ruan X; Chen T; Gudin J; Couch JP; Chiravuri S
J Opioid Manag; 2010; 6(4):300-3. PubMed ID: 20862910
[TBL] [Abstract][Full Text] [Related]
26. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
27. Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.
Setnik B; Sommerville K; Goli V; Han L; Webster L
Pain Med; 2013 Aug; 14(8):1173-86. PubMed ID: 23745947
[TBL] [Abstract][Full Text] [Related]
28. Morphine/naltrexone.
Duggan ST; Scott LJ
CNS Drugs; 2010 Jun; 24(6):527-38. PubMed ID: 20443648
[TBL] [Abstract][Full Text] [Related]
29. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
30. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
31. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
[TBL] [Abstract][Full Text] [Related]
32. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
Fishman M
Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
34. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
36. Opioid formulations designed to resist/deter abuse.
Raffa RB; Pergolizzi JV
Drugs; 2010 Sep; 70(13):1657-75. PubMed ID: 20731474
[TBL] [Abstract][Full Text] [Related]
37. Advantages of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules in pain management.
Kapoor S
J Opioid Manag; 2012; 8(4):207. PubMed ID: 22941847
[No Abstract] [Full Text] [Related]
38. Morphine sulfate abuse-deterrent formulations for the treatment of chronic pain.
Fanelli A; Sorella MC; Ghisi D
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1157-1162. PubMed ID: 30403896
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
[TBL] [Abstract][Full Text] [Related]
40. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]